0 items USD 0.00Search
Your search for "Pharma Pipeline" gave back 26 results.
“Non-alcoholic steatohepataitis (NASH) Pipeline Analysis” gives comprehensive insights on the various drugs being developed for the treatment of NASH...
IQ4I
October 2019
Price: USD 3,600.00
“Lutetium-177 Global Market Analysis” gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of GEP-NET,...
IQ4I
February 2020
Price: USD 3,600.00
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products...
Catalog:
CBR Pharma Insights
January 2018
Price: USD 2,995.00
This report provides a landscape description and analysis of chimeric antigen receptor-macrophage (CAR-M) platform technologies and stakeholders from...
Catalog:
La Merie Publishing
February 2023
Price: USD 2,000.00
Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Summary GBI Research’s latest report, “Innovation...
CBR Pharma Insights
May 2017
Price: USD 2,995.00
This report evaluates Receptor tyrosine kinase-like Orphan Receptor 1 (ROR1) from an industry perspective for its suitability as a tumor-specific...
Catalog:
La Merie Publishing
June 2022
Price: USD 1,170.00
This report bundle includes four reports about novel cancer targets which have in common a compelling target expression profile with a low risk of on...
Catalog:
La Merie Publishing
July 2022
Price: USD 2,000.00
Over the last two decades, the Pharmaceutical industry has seen a radical change. The unprecedented downsizing of the internal discovery of big...
Catalog:
IQ4I
May 2021
Price: USD 7,200.00
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and...
Catalog:
La Merie Publishing
May 2020
Price: USD 2,350.00
This report evaluates G-protein–coupled receptor family C group 5 member D (GPRC5D) from an industry perspective for its suitability as a tumor-...
Catalog:
La Merie Publishing
July 2022
Price: USD 670.00
Pharmaceutical Lifecycle Management Strategies in 2017 Summary GBI Research’s latest report, "Pharmaceutical Lifecycle Management Strategies in...
CBR Pharma Insights
April 2017
Price: USD 2,995.00
Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence...
Grace Market Data
November 2023
Price: USD 2,600.00
North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the...
Grace Market Data
November 2023
Price: USD 2,600.00
Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by...
Grace Market Data
November 2023
Price: USD 2,600.00
Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of...
Grace Market Data
November 2023
Price: USD 3,200.00
